Oramed Pharmaceuticals Inc (ORMP)

[navyvet]

I agree. While I am not excited about possibility of dilution up to $250 million worth of common shares, I do believe their intentions are to offer these at higher levels when positive phase 1 results are achieved, or maybe before results are released and we have a larger stock increase on anticipation of results. This could fund many trials through phase 3 along with research and development of Oravax creating new vaccine pills. Hopefully they don't dilute a bunch at these levels and I will watch closely each quarter financial statement to see how much was sold on the open market. But optimistic this means they expect much higher stock price to take advantage of coming up.